Experience sharing on perioperative clinical management of gastric cancer patients based on the "China Robotic Gastric Cancer Surgery Guidelines"
- PMID: 39054562
- PMCID: PMC11271040
- DOI: 10.1186/s13741-024-00402-x
Experience sharing on perioperative clinical management of gastric cancer patients based on the "China Robotic Gastric Cancer Surgery Guidelines"
Abstract
Background: With the popularization of robotic surgical systems in the field of surgery, robotic gastric cancer surgery has also been fully applied and promoted in China. The Chinese Guidelines for Robotic Gastric Cancer Surgery was published in the Chinese Journal of General Surgery in August 2021.
Methods: We have made a detailed interpretation of the process of robotic gastric cancer surgery regarding the indications, contraindications, perioperative preparation, surgical steps, complication, and postoperative management based on the recommendations of China's Guidelines for Robotic Gastric Cancer Surgery and supplemented by other surgical guidelines, consensus, and single-center experience.
Results: Twenty experiences of perioperative clinical management of robotic gastric cancer surgery were described in detail.
Conclusion: We hope to bring some clinical reference values to the front-line clinicians in treating robotic gastric cancer surgery.
Trial registration: The guidelines were registered on the International Practice Guideline Registration Platform ( http://www.guidelines-registry.cn ) (registration number: IPGRP-2020CN199).
Keywords: China; Experience sharing; Gastric cancer; Guidelines; Robotic surgery.
© 2024. The Author(s).
Conflict of interest statement
This article cites Recommendations 1–17 of the Chinese Guidelines for Robotic Gastric Cancer Surgery in Part 2 for the purpose of sharing further experience in robotic gastric cancer surgery on this basis. I was a key member of the guideline development team and participated in the preparation of the guideline throughout. All members of the guideline development team participated in the signing process of this article, and there is no conflict of interest after consultation. All authors agree to have it published.
The authors declare no competing interests.
Similar articles
-
Protocol for expanded indications of endoscopic submucosal dissection for early gastric cancer in China: a multicenter, ambispective, observational, open-cohort study.BMC Cancer. 2020 Aug 24;20(1):801. doi: 10.1186/s12885-020-07312-3. BMC Cancer. 2020. PMID: 32831061 Free PMC article.
-
Robotic Abdominal Surgery and COVID-19: A Systematic Review of Published Literature and Peer-Reviewed Guidelines during the SARS-CoV-2 Pandemic.J Clin Med. 2022 May 24;11(11):2957. doi: 10.3390/jcm11112957. J Clin Med. 2022. PMID: 35683346 Free PMC article. Review.
-
Clinical practice guideline for the management of hypertension in China.Chin Med J (Engl). 2024 Dec 20;137(24):2907-2952. doi: 10.1097/CM9.0000000000003431. Epub 2024 Dec 9. Chin Med J (Engl). 2024. PMID: 39653517 Free PMC article.
-
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247. Zhonghua Jie He He Hu Xi Za Zhi. 2024. PMID: 38309959 Chinese.
-
[Current situation and reflection on the robotic gastric cancer surgery in China].Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Apr 25;23(4):332-335. doi: 10.3760/cma.j.cn.441530-20200113-00020. Zhonghua Wei Chang Wai Ke Za Zhi. 2020. PMID: 32306598 Review. Chinese.
References
-
- Aoyama T, Yoshikawa T, Shirai J, et al. Postoperative anastomotic hemorrhage after gastrectomy. Gan to Kagaku Ryoho. 2012;39(12):2298–300. PMID: 23268056. - PubMed
-
- Bi C, Kong L, Qiao Y. Perioperative nursing experience of six cases of da Vinci robot-assisted gastrectomy. Contemp Nurs (Lower J). 2013;6(9):35–7 doi: CNKI:SUN:DDHZ.0.2013-09-020.
Publication types
Grants and funding
- 2019PT320005/Key Laboratory of Gastrointestinal Tumor Diagnosis and Treatment of National Health Commission of the People's Republic of China
- 2019PT320005/Key Laboratory of Gastrointestinal Tumor Diagnosis and Treatment of National Health Commission of the People's Republic of China
- 18JR2RA033/Key Laboratory of Molecular Diagnosis and Precision Therapy of Surgical Tumors in Gansu Province
- 18JR2RA033/Key Laboratory of Molecular Diagnosis and Precision Therapy of Surgical Tumors in Gansu Province
- 18JR2RA033/Key Laboratory of Molecular Diagnosis and Precision Therapy of Surgical Tumors in Gansu Province
LinkOut - more resources
Full Text Sources